Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Cancer Cell ; 4(4): 277-89, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14585355

RESUMO

Angiogenic defects in Id mutant mice inhibit the growth of tumor xenografts, providing a genetic model for antiangiogenic stress. Our work tests the consequences of such stress on progression of more physiological Pten+/- tumors. While tumor growth occurs despite impaired angiogenesis, disruption of vasculature by Id loss causes tumor cells to experience hypoxia and necrosis, the extent of which is tumor dependent. We show that bone-marrow-derived endothelial precursors contribute functionally to neovasculature of some but not all Pten+/- tumors, partially rescuing Id mutant phenotype. We demonstrate that loss of Id1 in tumor endothelial cells results in downregulation of several proangiogenic genes, including alpha6 and beta4 integrins, matrix metalloprotease-2, and fibroblast growth factor receptor-1. Inhibition of these factors phenocopies loss of Id in in vivo angiogenesis assays.


Assuntos
Medula Óssea/metabolismo , Células Endoteliais/metabolismo , Neovascularização Patológica/metabolismo , Proteínas Repressoras , Fatores de Transcrição/metabolismo , Animais , Hipóxia Celular , Células Cultivadas , Endotélio Vascular/fisiopatologia , Feminino , Proteínas de Peixes , Proteína 1 Inibidora de Diferenciação , Proteínas Inibidoras de Diferenciação , Integrina alfa6/metabolismo , Integrina beta4/metabolismo , Linfonodos/fisiopatologia , Metaloproteinase 2 da Matriz/metabolismo , Camundongos , Camundongos Knockout , Proteínas de Neoplasias/metabolismo , Neoplasias Experimentais/fisiopatologia , PTEN Fosfo-Hidrolase , Proteína Tirosina Fosfatase não Receptora Tipo 1 , Proteínas Tirosina Fosfatases/genética , Proteínas Tirosina Fosfatases/metabolismo , Receptores Proteína Tirosina Quinases/metabolismo , Receptor Tipo 1 de Fator de Crescimento de Fibroblastos , Receptores de Fatores de Crescimento de Fibroblastos/metabolismo , Trombospondina 1/metabolismo , Fatores de Transcrição/genética , Transplante Heterólogo , Neoplasias Uterinas/fisiopatologia
2.
PLoS Biol ; 6(5): e119, 2008 May 20.
Artigo em Inglês | MEDLINE | ID: mdl-18494558

RESUMO

The Clock-Cycle (CLK-CYC) heterodimer constitutes a key circadian transcription complex in Drosophila. CYC has a DNA-binding domain but lacks an activation domain. Previous experiments also indicate that most of the transcriptional activity of CLK-CYC derives from the glutamine-rich region of its partner CLK. To address the role of transcription in core circadian timekeeping, we have analyzed the effects of a CYC-viral protein 16 (VP16) fusion protein in the Drosophila system. The addition of this potent and well-studied viral transcriptional activator (VP16) to CYC imparts to the CLK-CYC-VP16 complex strongly enhanced transcriptional activity relative to that of CLK-CYC. This increase is manifested in flies expressing CYC-VP16 as well as in S2 cells. These flies also have increased levels of CLK-CYC direct target gene mRNAs as well as a short period, implicating circadian transcription in period determination. A more detailed examination of reporter gene expression in CYC-VP16-expressing flies suggests that the short period is due at least in part to a more rapid transcriptional phase. Importantly, the behavioral effects require a period (per) promoter and are therefore unlikely to be merely a consequence of generally higher PER levels. This indicates that the CLK-CYC-VP16 behavioral effects are a consequence of increased per transcription. All of this also suggests that the timing of transcriptional activation and not the activation itself is the key event responsible for the behavioral effects observed in CYC-VP16-expressing flies. The results taken together indicate that circadian transcription contributes to core circadian function in Drosophila.


Assuntos
Ritmo Circadiano/fisiologia , Drosophila melanogaster/genética , Drosophila melanogaster/metabolismo , Transcrição Gênica , Fatores de Transcrição ARNTL , Animais , Animais Geneticamente Modificados , Fatores de Transcrição Hélice-Alça-Hélice Básicos/genética , Fatores de Transcrição Hélice-Alça-Hélice Básicos/metabolismo , Proteínas CLOCK , Linhagem Celular , Ritmo Circadiano/genética , Proteínas de Drosophila/genética , Proteínas de Drosophila/metabolismo , Proteína Vmw65 do Vírus do Herpes Simples/genética , Atividade Motora/genética , Proteínas Nucleares/genética , Análise de Sequência com Séries de Oligonucleotídeos , Proteínas Circadianas Period , RNA Mensageiro/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Fatores de Tempo , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismo , Asas de Animais/metabolismo
3.
Proc Natl Acad Sci U S A ; 101(7): 1927-32, 2004 Feb 17.
Artigo em Inglês | MEDLINE | ID: mdl-14762164

RESUMO

RNA interference is a powerful genetic approach for efficiently silencing target genes. The existing method of gene suppression by the constitutive expression of short hairpin RNAs (shRNAs) allows analysis of the consequences of stably silencing genes but limits the analysis of genes essential for cell survival, cell cycle regulation, and cell development. We have developed an inducible U6 promoter for synthesis of shRNAs in both human and murine cells. Cells containing stably integrated shRNA expression constructs demonstrate stringent dosage- and time-dependent kinetics of induction with undetectable background expression in the absence of the inducer ecdysone. Inducible suppression of human p53 in glioblastoma cells shows striking morphological changes and defects in cell cycle arrest caused by DNA damage, as expected. Remarkably, the inducibility is reversible after withdrawal of the inducer, as observed by reappearance of the protein and a restoration of the original cell phenotype. Inducible and reversible regulation of RNA interference has broad applications in the areas of mammalian genetics and molecular therapeutics.


Assuntos
Técnicas Genéticas , Interferência de RNA , Ativação Transcricional , Animais , Linhagem Celular , Ecdisona/farmacologia , Vetores Genéticos/genética , Humanos , Camundongos , Proteína MyoD/biossíntese , Proteína MyoD/genética , RNA/genética , RNA/metabolismo , Reprodutibilidade dos Testes , Retroviridae/genética , Ativação Transcricional/efeitos dos fármacos , Proteína Supressora de Tumor p53/biossíntese , Proteína Supressora de Tumor p53/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA